Stockreport

Revolution Medicines Full Year 2023 Earnings: Misses Expectations [Yahoo! Finance]

Revolution Medicines, Inc.  (RVMD) 
PDF Net loss: US$436.4m (loss widened by 76% from FY 2022). US$3.86 loss per share (further deteriorated from US$3.09 loss in FY 2022). RVMD Products In Clinical Trials [Read more]